Salarius Pharmaceuticals Statistics Share Statistics Salarius Pharmaceuticals has 509.71K
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 509.71K Shares Change (YoY) 0% Shares Change (QoQ) -0.92% Owned by Institutions (%) 6.11% Shares Floating 506.25K Failed to Deliver (FTD) Shares 6,739 FTD / Avg. Volume 3.02%
Short Selling Information The latest short interest is 803.61K, so 37.78% of the outstanding
shares have been sold short.
Short Interest 803.61K Short % of Shares Out 37.78% Short % of Float 37.97% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.32 and the forward
PE ratio is -0.02.
Salarius Pharmaceuticals's PEG ratio is
0.
PE Ratio -0.32 Forward PE -0.02 PS Ratio 0 Forward PS 0.3 PB Ratio 1.18 P/FCF Ratio -0.39 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Salarius Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.98,
with a Debt / Equity ratio of 0.15.
Current Ratio 1.98 Quick Ratio 1.98 Debt / Equity 0.15 Debt / EBITDA -0.04 Debt / FCF -0.05 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.79M Employee Count 2 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -75.51% in the
last 52 weeks. The beta is 0.45, so Salarius Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.45 52-Week Price Change -75.51% 50-Day Moving Average 10.5 200-Day Moving Average 16.92 Relative Strength Index (RSI) 37.37 Average Volume (20 Days) 223,423
Income Statement
Revenue n/a Gross Profit -4.42K Operating Income -5.73M Net Income -5.58M EBITDA -5.57M EBIT -5.58M Earnings Per Share (EPS) -86.85
Full Income Statement Balance Sheet The company has 2.43M in cash and 221.87K in
debt, giving a net cash position of 2.21M.
Cash & Cash Equivalents 2.43M Total Debt 221.87K Net Cash 2.21M Retained Earnings -81.92M Total Assets 1.39M Working Capital -122.37K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -4.53M
and capital expenditures 0, giving a free cash flow of -4.53M.
Operating Cash Flow -4.53M Capital Expenditures n/a Free Cash Flow -4.53M FCF Per Share -70.2
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields SLRX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for SLRX.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 18, 2025. It was a
backward
split with a ratio of 1:15.
Last Split Date Aug 18, 2025 Split Type backward Split Ratio 1:15
Scores Altman Z-Score -96.41 Piotroski F-Score 1
